SAN FRANCISCO--(BUSINESS WIRE)--After securing over $130M in funding and achieving multiple regulatory successes, Unlearn today announced changes to its executive leadership to support the commercial ...

Using novel digital twins of clinical trial participants, Unlearn is accelerating clinical research to help bring new treatments to patients sooner SAN FRANCISCO--(BUSINESS WIRE)--Unlearn®, an AI ...

Unlearn, an AI-enabled company creating digital twins of clinical trial participants, announced a partnership to advance ALS research with biotechnology company Trace Neuroscience, which creates ...

SAN FRANCISCO, CA AND NEW YORK, NY / ACCESS Newswire / February 24, 2026 / Unlearn, a leading artificial intelligence company in the clinical development space, today announced its use of data from ...